Abstract
Background
In pediatric patients with small-cell tumors, there is an increasing demand for accurate and early detection of skeletal, especially bone marrow, metastases as new treatment protocols are introduced. Whole-body MR imaging (WB-MR) and 18F-fluorodeoxyglucose PET/CT (FDG PET/CT) are new promising imaging methods that can detect metastases before osteoblastic host response occurs, which is the basis for detection of metastases by skeletal scintigraphy (SSC).
Objective
To assess the ability of WB-MR to detect marrow metastases in children with small-cell neoplasms and compare its performance with that of FDG PET/CT and SSC.
Materials and methods
During a 16-month period, 26 children and adolescents with histopathologically proven small-cell neoplasms underwent WB-MR, FDG PET/CT and Tc-phosphonate-based SSC in a random order within a 25-day period. Metastases were localized in relation to eight regions of the body.
Results
WB-MR revealed metastases in 39 out of a total of 208 regions in 26 patients (sensitivity 97.5%, specificity 99.4%, positive predictive value 97.5%, negative predictive value 99.4%), SSC in 12 regions (sensitivity 30%, specificity 99.4%, PPV 92.3%, NPV 85.6%) and FDG PET/CT in 36 regions (sensitivity 90.0%, specificity 100%, PPV 100%, NPV 97.7%). Both WB-MR and FDG PET/CT showed excellent agreement (kappa) with the final diagnosis (96.9% and 93.6% respectively), whereas SSC showed only moderate agreement (39.6%).
Conclusion
Our results suggest that WB-MR and FDG PET/CT studies are robust imaging modalities for screening for skeletal metastases, and are far more accurate than SSC. The lack of radiation is an additional advantage of WB-MR, especially in the pediatric population.
Similar content being viewed by others
References
Daldrup-Link HE, Franzius C, Link TM et al (2001) Whole-body MR imaging for the detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR 177:229–236
Mazumdar A, Seigel MJ, Narra V et al (2002) Whole-body fast inversion recovery MR imaging of small cell neoplasms in pediatric patients: a pilot study. AJR 179:1261–1266
Mirza I, Cuello B, Ramachandran A et al (2001) Bone marrow biopsy and bone scan to detect metastases. Clin Nucl Med 26:677–679
Schmidt GP, Baur-Melnyk A, Herzog P et al (2005) High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 40:743–753
Eustace S, Tello R, DeCarvalho V et al (1997) A comparison of whole-body turbo STIR MR imaging and planar 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR 169:1655–1661
Kellenberger CJ, Epelman M, Miller SF et al (2004) Fast STIR whole-body MR imaging in children. Radiographics 24:1317–1330
Kellenberger CJ, Miller SF, Khan M et al (2004) Initial experience with FSE STIR whole-body MR imaging for staging lymphoma in children. Eur Radiol 14:1829–1841
Mentzel HJ, Kentouche K, Sauner D et al (2004) Comparison of whole-body STIR-MRI and 99m Tc-methylene diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14:2297–2302
Subramanian G, McAfee JG, Blair RJ et al (1975) Technetium-99m-methylene diphosphonate – a superior agent for skeletal imaging: comparison with other technetium complexes. J Nucl Med 16:744–755
Brix G, Lechel U, Glatting G et al (2005) Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations. J Nucl Med 46:608–613
Goo HW, Choi SH, Ghim T et al (2005) Whole-body MRI of paediatric malignant tumours: comparison with conventional oncological imaging methods. Pediatr Radiol 35:766–773
Steinborn MM, Heuck AF, Tiling R et al (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129
Schmidt GP, Schoenberg SO, Schmid R et al (2007) Screening for bone metastases: whole-body MRI using a 32-channel system versus dual-modality PET-CT. Eur Radiol 17:939–949
Ricci C, Cova M, Kang Y et al (1990) Normal age related patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 177:83–88
Kricun M (1985) Red-yellow marrow conversion: its effect on the location of some solitary bone lesions. Skeletal Radiol 14:10–19
Moore S, Dawson K (1990) Red and yellow marrow in the femur: age related changes in appearance at MRI. Radiology 175:219–223
American College of Radiology Imaging Network (2006) Protocol 6660. Whole-body MRI in the evaluation of pediatric malignancies. Study accrual closed on 29 June 2007. http://www.acrin.org/TabID/184/Default.aspx. Accessed 27 June 2008
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kumar, J., Seith, A., Kumar, A. et al. Whole-body MR imaging with the use of parallel imaging for detection of skeletal metastases in pediatric patients with small-cell neoplasms: comparison with skeletal scintigraphy and FDG PET/CT. Pediatr Radiol 38, 953–962 (2008). https://doi.org/10.1007/s00247-008-0921-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00247-008-0921-y